[1]
R.H. Muller, W. Mehnert, J.S. Lucks. Solid lipid nanoparticles-an alternative colloidal carrier system for controlled drug deleviry. Eur. J. Pharm. Biopharm. Vol. 41 (1995), p.62
Google Scholar
[2]
R.H. Muller, M. Radtke, S.A. Wissing. Solid lipid nanopaticles and nanostructured lipid carries in cosmetic and dermatological preparations. Adv. Drug. Rev. Vol. 1 (2002), P. 131
DOI: 10.1016/s0169-409x(02)00118-7
Google Scholar
[3]
V. Jenning, A.F. Thunemann, S.H. Gohla. Characterization of a novel solid lipid nanoparticle carrier system based on binary mixture of liquid and solid lipids. Int. J. Pharm. Vol. 199 (2000), p.167
DOI: 10.1016/s0378-5173(00)00378-1
Google Scholar
[4]
V. Vobalaboina, M. Kopparam. Preparation, characterization an in vitro release kinetics of clozapine solid lipid nanoparticles. J. Controlled Rlease. Vol. 95 (2004), p.627
DOI: 10.1016/j.jconrel.2004.01.005
Google Scholar
[5]
K. Sato, S. Ueno, J. Yano. Molecular interactions and kinetic properties of fats. Prog. Lipid Res. Vol. 38 (1999), p.91
DOI: 10.1016/s0163-7827(98)00019-8
Google Scholar
[6]
A.K. Gupta, M. Browne, R. Bluhm. Imiquimod: A Review. J Cutan Med Surg. Vol. 6 (2002),p.554
Google Scholar
[7]
B. Siekmann, K. Westesen. Thermo-analysis of the recrystallization process of melthomogeniz- ed glycerid nanoparticles. Colloids Surf B. Vol. 6 (1994), p.159
Google Scholar
[8]
D.Z Hou, C.S Xie, K.J Huang. The production and characteristics of solid lipid nanoparticles, Biomaterials. Vol. 24 (2003), p.1781
Google Scholar
[9]
J.R. Heylings, S. Diot, D.J. Esdaile, et al. A prevalidation study on the in vitro skin irritation function test (SIFT) for prediction of acute skin irritation in vivo: results and evaluation of ECVAM Phase III [J]. Toxicol In Vitro, Vol. 17 (2003), p.123
DOI: 10.1016/s0887-2333(02)00130-3
Google Scholar